The New York Times reports that Biomet's federal probation was set to expire next week, but new evidence of foreign bribery has extended it by a year. During that time, the Justice Department will investigate the issue. Additionally, the Justice Department will be looking into whether Biomet was involved in the bribery of … [Read more...] about Biomet Probation Extended by a Year in Light of New Bribery Evidence

While clinical trial results for AstraZeneca's heart drug Brilinta (ticagrelor) are positive, the trail showed bleeding risks with the blood-thinning drug. A 21,000-patient clinical trial showed Brilinta (ticagrelor) cuts heart attacks and strokes, but caused more bleeding, Reuters reports. … [Read more...] about Brilinta May Prevent Heart Attacks But Can Raise Bleeding Risks